Clinical Research Directory
Browse clinical research sites, groups, and studies.
Immune Response to High-Dose vs. Standard Dose Influenza Vaccine
Sponsor: Health Sciences North Research Institute
Summary
This 5-year proposal is a randomized study of split-virus influenza vaccine (SVV) in a high-dose (HD) vs. standard-dose (SD) formulation in each of five influenza seasons to define the key determinants of vaccine-mediated protection against influenza and how these immunologic mediators may be enhanced by vaccination with a newly approved high-dose influenza vaccine in older people
Key Details
Gender
All
Age Range
20 Years - Any
Study Type
INTERVENTIONAL
Enrollment
393
Start Date
2014-02-01
Completion Date
2026-09-21
Last Updated
2026-10-05
Healthy Volunteers
Yes
Conditions
Interventions
Flu Vaccine
Locations (2)
Center on Aging, UConn Health
Farmington, Connecticut, United States
Health Sciences North Research Institute
Greater Sudbury, Ontario, Canada